• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NMS
    1.71 Up 0.05(3.01%) Feb 12, 4:00PM EST
    |After Hours : 1.71 Up 0.00 (0.02%) Feb 12, 5:07PM EST
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (45,189) (30,108) (39,081)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation616  743  1,067  
    Adjustments To Net Income4,717  (973)4,916  
    Changes In Accounts Receivables(7,375)2,447  1,269  
    Changes In Liabilities11,247  (3,152)(7,509)
    Changes In Inventories(683) -  263  
    Changes In Other Operating Activities(1,884)4,513  1,678  
    Total Cash Flow From Operating Activities (38,551) (26,530) (37,397)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(106)(30)(113)
    Investments(39,875)(3,644)24,680  
    Other Cash flows from Investing Activities1  207  317  
    Total Cash Flows From Investing Activities (39,980) (3,467) 24,884  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock111,907  25,090  18,660  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 111,907   30,270   16,960  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 33,376   273   4,447  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.